Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi Health's gross profit for the
three
months ended in Mar. 2026 was $0.07 Mil. Optimi Health's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.14 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Optimi Health's gross profit for the
three
months ended in Mar. 2026 was $0.07 Mil. Optimi Health's Revenue for the
three
months ended in Mar. 2026 was $0.07 Mil. Therefore, Optimi Health's Gross Margin % for the quarter that ended in Mar. 2026 was 89.04%.
Optimi Health had a gross margin of 89.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
During the past 6 years, the highestGross Margin % of Optimi Health was 110.50%. The lowest was -83.19%. And the median was 68.08%.
Optimi Health (OTCPK:OPTHF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Optimi Health had a gross margin of 89.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Optimi Health Gross Profit Related Terms
Optimi Health Gross Profit Historical Data
* Premium members only.
The historical data trend for Optimi Health's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health Gross Profit vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Gross Profit distribution charts can be found below:
* The bar in red indicates where Optimi Health's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Optimi Health (OPTHF) has a Gross Profit of $-0.14 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Optimi Health and its competitors.
Is Optimi Health's Gross Profit too high?
Optimi Health's current Gross Profit is $-0.14 Mil. Overall, Optimi Health has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Gross Profit compare to ZTS?
Optimi Health's Gross Profit of $-0.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Optimi Health and its competitors. Optimi Health's current Gross Profit is $-0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Optimi Health (OPTHF) has a current Gross Profit of $-0.14 Mil. The stock's GF Value™ is $0.21, compared to a current price of $0.24 — trading 12% above its estimated fair value. The current Gross Profit is $-0.14 Mil. Optimi Health's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Optimi Health (OPTHF), the current Gross Profit is $-0.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $0.24 is trading 12% above its estimated GF Value™ of $0.21.
Key valuation signals for OPTHF:
Gross Profit: $-0.14 Mil
GF Value™: $0.21 vs. price of $0.24 (12% above fair value)
No single metric tells the full story. See the OPTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
47GF Score
Get the complete analysis for OPTHF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTHF has been successfully added to your 
